Home
Home » companies

Amgen

Amgen Inc (AMGN): Today's Featured Drugs Laggard

Amgen Inc (AMGN): Today's Featured Drugs Laggard
The Street

Will Generic Competitors Of Enbrel Affect Amgen's Stock Price?

Will Generic Competitors Of Enbrel Affect Amgen's Stock Price?
Seeking Alpha

FDA approves new use for Amgen drug Xgeva, for rare type of bone tumors seen in young adults

FDA approves new use for Amgen drug Xgeva, for rare type of bone tumors seen in young adults
Yahoo/AP

Amgen says drug slowed ovarian cancer in trial

Amgen says drug slowed ovarian cancer in trial
Reuters

Cytokinetics and Amgen add Japan to collaboration on heart failure drug in $25 million deal

Cytokinetics and Amgen add Japan to collaboration on heart failure drug in $25 million deal
Yahoo/AP

New Data Improves Sales Outlook For Celgene's Apremilast

New Data Improves Sales Outlook For Celgene's Apremilast
TheStreet.com

It's Time to Buy Amgen Stock. Here's Why

It's Time to Buy Amgen Stock. Here's Why
Motley Fool

Generic Threats To Amgen's Biologics

Generic Threats To Amgen's Biologics
Seeking Alpha

Old-School Pharma/Biotech Dividend Paying Comparison

Old-School Pharma/Biotech Dividend Paying Comparison
Seeking Alpha

Amgen melanoma drug improved survival by 21 pct in interim look

Amgen melanoma drug improved survival by 21 pct in interim look
Reuters